Papers
1
Total Citations
14
H-Index
1
About
Dr. Songqiang Cao has made significant contributions to the field of urologic oncology, with a primary focus on improving surgical outcomes for bladder cancer patients. His research centers on identifying preoperative risk factors that predict mortality following radical cystectomy, particularly in the context of robot-assisted procedures. In his most cited work, Cao developed a predictive model for early death risk within one year of surgery, utilizing readily available laboratory data to stratify patients preoperatively. This study, published in 2019 and garnering 14 citations, provides clinicians with a practical tool to enhance preoperative counseling and optimize treatment strategies for high-risk individuals. By integrating clinical biomarkers with surgical planning, Cao’s work addresses a critical gap in personalized cancer care, aiming to reduce postoperative mortality and improve long-term survival. His findings underscore the importance of early risk assessment in bladder cancer management, offering actionable insights for surgeons and oncologists. Through this research, Cao has advanced the evidence base for robot-assisted radical cystectomy, contributing to safer and more tailored surgical approaches in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1